SHARPS TECHNOLOGY INC (STSS)
US82003F1012 - Common Stock
STSS Stock Earnings: Sharps Technology Reported Results for Q4 2023
Sharps Technology just reported results for the fourth quarter of 2023.
Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems
Sharps and Roncadelle are Joining Forces to Sell and Distribute their Securegard, SAFER, and Sologard Lines of Disposable Smart Safety Syringes and Expand...
Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems
Sharps and Roncadelle are Joining Forces to Supply Drug Delivery Systems to the International HealthCare Market Through an Expanded Network of North...
Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
Agreement would result in Sharps and Roncadelle Joining Forces to Access Global Healthcare Organizations Through More Than 30 Sales Partners worldwide...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Sharps Technology director Timothy Ruemler buys 15K common shares (NASDAQ:STSS)
Director Timothy Ruemler purchases 15K shares of Sharps Technology (STSS) at an average price of $0.41/share, according to an SEC filing.
Sharps Technology to sell 11.33M shares for holders (NASDAQ:STSS)
Sharps Technology (STSS) has filed a prospectus for the resale of common shares by selling stockholders, but the prospectus is not an offer to sell those...
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement
Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement...
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals
Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing...
UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and...
Sharps Technology announces $5.6M registered direct and private placement (NASDAQ:STSS)
Sharps Technology (STSS) announces registered direct offering of 4.42M shares and pre-funded warrants with institutional investors.
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules...
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END